血漿分画の2030年までの市場予測調査レポートPlasma Fractionation Market Research Report Forecast to 2030 血漿分画の2030年までの市場予測調査レポート 市場概要 血漿分画市場は、予測期間中に9.1%の健全なCAGRを記録すると予測される。様々な支持領域に対する免疫グロブリンの使用の増加と、血漿から分化された修... もっと見る
サマリー血漿分画の2030年までの市場予測調査レポート市場概要 血漿分画市場は、予測期間中に9.1%の健全なCAGRを記録すると予測される。様々な支持領域に対する免疫グロブリンの使用の増加と、血漿から分化された修復物への関心が、市場の改善を促進する市場の進歩を促進する。 免疫グロブリンは、さまざまな神経学的、免疫学的、血液学的疾患の第一選択薬として使用されている。近年、様々な免疫疾患の発見スピードは、機械的な進歩の観点から、ある程度まで伸びている。免疫不全の描写と診断のための遺伝的評価の創出も同様に、解剖された患者数の拡大という観点から、免疫グロブリンの臨床的必要性を拡大するだろう。さらに、前例のない安全な骨格疾患の発生が避けられず、免疫学研究が拡大していることが、この分野の発展をさらに後押ししている。2022年2月にPublic Spot for Advancing Translational Sciencesが発表したデータによると、個人に影響を与える前例のない病気は約7000〜10000種類あり、そのうち治療を受けているのは数百種類である。さらに、人々を魅了する病気の数が増加していることが、免疫グロブリン市場分野の発展に拍車をかけている。 市場セグメント 血漿分画市場の製品タイプ別セグメントには、免疫グロブリン、凝固因子濃縮物、アルブミン、プロテアーゼ阻害剤、その他が含まれます。 用途に基づく血漿分画市場は、免疫学、神経学、血液学、クリティカルケア、呼吸器学、リウマチ学、血液腫瘍学、その他に分類される。エンドユーザー別では、病院・診療所、臨床研究所、学術機関、その他に分類される。 地域別洞察 北米の血漿分画市場は2022年に最大の市場シェアを占めた。この背景には、さまざまな遺伝性疾患の蔓延、老年人口の増加、同地域における医療利用の拡大がある。アルツハイマー病の高い一般性と、治療における血漿分画アイテムの実行可能性が、測定期間中の市場発展を支えている。欧州の血漿分画市場は2番目に大きな市場シェアを占めているが、これは同地域における免疫不全と消耗性疾患の優位性の高まりと、これらのフレームワークへの関心の拡大によるものである。 アジア太平洋の血漿分画市場は、2023年から2032年にかけて重要なオファーで発展することになっている。この背景には、革新的な仕事に対する公然かつ秘密裏の助成金の拡大、偉大な非公式の法律、免疫グロブリンの利用拡大、血液関連疾患を持つ成熟した人口に伴う対象疾患の一般性の上昇、アジア太平洋地域における血漿ベースの治療受付の増加がある。 それ以外の地域は、中東、アフリカ、ラテンアメリカに細分化されます。前述の地域の血漿分画市場は、おそらく、この地域における免疫系疾患の一般的なため、発展を観察するつもりです。さらに、ベドウィン首長国連邦(UAE)、サウジアラビア、南アフリカは、MEAの3つの重要な国である。 主要プレーヤー 血漿分画市場の主要企業は、CSL Behring(米国)、Grifols Therapeutics(スペイン)、Baxter International Inc(米国)、Hualan Bio(中国)、田辺三菱製薬(日本)、武田薬品工業(日本)、Octapharma AG(スイス)、Kedrion S.p.A(イタリア)、LFB Group(フランス)、Biotest AG(ドイツ)である。 目次TABLE OF CONTENTS1 EXECUTIVE SUMMARY 1.1.1 GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE 1.1.2 GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION 1.1.3 GLOBAL PLASMA FRACTIONATION MARKET, BY END USER 1.1.4 GLOBAL PLASMA FRACTIONATION MARKET, BY REGION 2 MARKET INTRODUCTION 2.1 DEFINITION 2.2 SCOPE OF THE STUDY 2.3 SCOPE OF THE STUDY 2.4 MARKET STRUCTURE 3 RESEARCH METHODOLOGY 3.1 RESEARCH PROCESS 3.2 PRIMARY RESEARCH 3.3 SECONDARY RESEARCH 3.4 MARKET SIZE ESTIMATION 3.5 TOP DOWN & BOTTOM-UP APPROACH 3.6 FORECAST MODEL 3.7 LIST OF ASSUMPTIONS 4 MARKET DYNAMICS 4.1 DRIVERS 4.1.1 GROWING USE OF IMMUNOGLOBULINS FOR VARIOUS THERAPEUTIC AREA 4.1.2 DEMAND FOR PLASMA DERIVED MEDICINAL PRODUCTS DRIVES THE MARKET GROWTH 4.1.3 DRIVER IMPACT ANALYSIS 4.2 RESTRAINTS 4.2.1 EMERGENCE OF RECOMBINANT THERAPIES AS AN ALTERNATIVE TO PLASMA DERIVED MEDICINES RESTRAINTS THE MARKET GROWTH 4.2.2 RESTRAINT IMPACT ANALYSIS 4.3 OPPORTUNITIES 4.3.1 LAUNCH OF NEW TECHNOLOGIES BY KEY PLAYERS TO AUGMENT MARKET GROWTH 5 MARKET FACTOR ANALYSIS 5.1 SUPPLY CHAIN ANALYSIS 5.1.1 RAW APPLICATIONS 5.1.2 MANUFACTURES 5.1.3 DISTRIBUTION 5.1.4 END USER 5.2 PORTER’S FIVE FORCES MODEL 5.2.1 THREAT OF NEW ENTRANTS 5.2.2 BARGAINING POWER OF SUPPLIERS 5.2.3 THREAT OF SUBSTITUTES 5.2.4 BARGAINING POWER OF BUYERS 5.2.5 INTENSITY OF RIVALRY 5.3 MAJOR COLD CHAIN PRODUCTS/DEVICES IN THE PLASMA FRACTIONATION MARKET 5.4 IMPACT OF COVID-19 ON THE GLOBAL PLASMA FRACTIONATION MARKET 5.4.1 IMPACT ON SUPPLY CHAIN 5.4.2 IMPACT ON PRODUCTION 5.4.3 IMPACT ON REGIONS 5.4.4 IMPACT ON DEMAND-SUPPLY GAP ANALYSIS 5.4.5 IMPACT ON PRICING 6 GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE 6.1 OVERVIEW 6.2 IMMUNOGLOBULIN 6.2.1 Intravenous Immunoglobulins 6.2.2 Subcutaneous Immunoglobulins 6.2.3 Others 6.3 COAGULATION FACTOR CONCENTRATES 6.3.1 Factor VIII 6.3.2 Factor IX 6.3.3 Von Willebrand Factor 6.3.4 Prothrombin Complex Concentrate 6.3.5 Fibrinogen Concentrates 6.3.6 Factor XIII 6.4 ALBUMIN 6.5 PROTEASE INHIBITORS 6.6 OTHERS 7 GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION 7.1 OVERVIEW 7.2 IMMUNOLOGY 7.3 NEUROLOGY 7.4 HEMATOLOGY 7.5 CRITICAL CARE 7.6 PULMONOLOGY 7.7 RHEUMATOLOGY 7.8 HEMATO-ONCOLOGY 7.9 OTHERS 8 GLOBAL PLASMA FRACTIONATION MARKET, BY END USER 8.1 OVERVIEW 8.2 HOSPITALS & CLINICS 8.3 CLINICAL RESEARCH LABORATORIES 8.4 ACADEMIC INSTITUTES 8.5 OTHERS 9 GLOBAL PLASMA FRACTIONATION, BY REGION 9.1 OVERVIEW 9.2 NORTH AMERICA 9.2.1 US 9.2.2 CANADA 9.3 EUROPE 9.3.1 GERMANY 9.3.2 FRANCE 9.3.3 ITALY 9.3.4 SPAIN 9.3.5 UK 9.3.6 REST OF EUROPE 9.4 ASIA-PACIFIC 9.4.1 CHINA 9.4.2 JAPAN 9.4.3 INDIA 9.4.4 AUSTRALIA 9.4.5 SOUTH KOREA 9.4.6 REST OF ASIA PACIFIC 9.5 REST OF THE WORLD 9.5.1 LATIN AMERICA 9.5.2 MIDDLE EAST 9.5.3 AFRICA 10 COMPETITIVE LANDSCAPE 10.1 COMPETITIVE OVERVIEW 10.2 MAJOR GROWTH STRATEGY IN THE GLOBAL PLASMA FRACTIONATION MARKET 10.3 COMPETITIVE BENCHMARKING 11 COMPANY PROFILES 11.1 CSL BEHRING 11.1.1 COMPANY OVERVIEW 11.1.2 FINANCIAL OVERVIEW 11.1.3 PRODUCTS OFFERED 11.1.4 KEY DEVELOPMENTS 11.1.5 SWOT ANALYSIS 11.1.6 KEY STRATEGIES 11.2 GRIFOLS THERAPEUTICS 11.2.1 COMPANY OVERVIEW 11.2.2 FINANCIAL OVERVIEW 11.2.3 PRODUCTS OFFERED 11.2.4 KEY DEVELOPMENTS 11.2.5 SWOT ANALYSIS 11.2.6 KEY STRATEGIES 11.3 BAXTER INTERNATIONAL INC. 11.3.1 COMPANY OVERVIEW 11.3.2 FINANCIAL OVERVIEW 11.3.3 PRODUCTS OFFERED 11.3.4 KEY DEVELOPMENTS 11.3.5 SWOT ANALYSIS 11.3.6 KEY STRATEGIES 11.4 MITSUBISHI TANABE 11.4.1 COMPANY OVERVIEW 11.4.2 FINANCIAL OVERVIEW 11.4.3 PRODUCTS OFFERED 11.4.4 KEY DEVELOPMENTS 11.4.5 SWOT ANALYSIS 11.4.6 KEY STRATEGIES 11.5 TAKEDA PHARMACEUTICAL 11.5.1 COMPANY OVERVIEW 11.5.2 FINANCIAL OVERVIEW 11.5.3 PRODUCTS OFFERED 11.5.4 KEY DEVELOPMENTS 11.5.5 SWOT ANALYSIS 11.5.6 KEY STRATEGIES 11.6 OCTAPHARMA AG 11.6.1 COMPANY OVERVIEW 11.6.2 FINANCIAL OVERVIEW 11.6.3 PRODUCTS OFFERED 11.6.4 KEY DEVELOPMENTS 11.6.5 SWOT ANALYSIS 11.6.6 KEY STRATEGIES 11.7 HUALAN BIO 11.7.1 COMPANY OVERVIEW 11.7.2 FINANCIAL OVERVIEW 11.7.3 PRODUCTS OFFERED 11.7.4 KEY DEVELOPMENTS 11.8 KEDRION S.P.A 11.8.1 COMPANY OVERVIEW 11.8.2 FINANCIAL OVERVIEW 11.8.3 PRODUCTS OFFERED 11.8.4 KEY DEVELOPMENTS 11.9 LFB GROUP 11.9.1 COMPANY OVERVIEW 11.9.2 FINANCIAL OVERVIEW 11.9.3 PRODUCTS OFFERED 11.9.4 KEY DEVELOPMENTS 11.10 BIOTEST AG 11.10.1 COMPANY OVERVIEW 11.10.2 FINANCIAL OVERVIEW 11.10.3 PRODUCTS OFFERED 11.10.4 KEY DEVELOPMENTS 11.10.5 SWOT ANALYSIS 11.10.6 KEY STRATEGIES 図表リストLIST OF TABLESTABLE 1 LIST OF ASSUMPTIONS TABLE 2 GLOBAL PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 3 IMMUNOGLOBULIN: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 4 IMMUNOGLOBULIN: MARKET ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD MILLION) TABLE 5 COAGULATION FACTOR CONCENTRATES: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 6 COAGULATION FACTOR CONCENTRATES: MARKET ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD MILLION) TABLE 7 ALBUMIN: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 8 PROTEASE INHIBITORS: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 9 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 10 GLOBAL PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 11 IMMUNOLOGY: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 12 NEUROLOGY: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 13 HEMATOLOGY: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 14 CRITICAL CARE: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 15 PULMONOLOGY: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 16 RHEUMATOLOGY: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 17 HEMATO-ONCOLOGY: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 18 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 19 GLOBAL PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 20 HOSPITALS & CLINICS: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 21 CLINICAL RESEARCH LABORATORIES: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 22 ACADEMIC INSTITUTES: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 23 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 24 GLOBAL PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 25 NORTH AMERICA: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2019-2032 (USD MILLION) TABLE 26 NORTH AMERICA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 27 NORTH AMERICA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 28 NORTH AMERICA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 29 US: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 30 US MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 31 US PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 32 CANADA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 33 CANADA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 34 CANADA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 35 EUROPE: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2019-2032 (USD MILLION) TABLE 36 EUROPE: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 37 EUROPE MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 38 EUROPE PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 39 GERMANY: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 40 GERMANY MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 41 GERMANY PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 42 FRANCE: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 43 FRANCE MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 44 FRANCE PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 45 ITALY: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 46 ITALY MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 47 ITALY PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 48 SPAIN: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 49 SPAIN MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 50 SPAIN PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 51 UK: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 52 UK MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 53 UK PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 54 REST OF EUROPE: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 55 REST OF EUROPE MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 56 REST OF EUROPE PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 57 ASIA-PACIFIC: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2019-2032 (USD MILLION) TABLE 58 ASIA PACIFIC: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 59 ASIA PACIFIC MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 60 ASIA PACIFIC PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 61 CHINA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 62 CHINA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 63 CHINA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 64 JAPAN: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 65 JAPAN MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 66 JAPAN PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 67 INDIA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 68 INDIA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 69 INDIA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 70 AUSTRALIA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 71 AUSTRALIA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 72 AUSTRALIA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 73 SOUTH KOREA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 74 SOUTH KOREA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 75 SOUTH KOREA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 76 REST OF ASIA PACIFIC: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 77 REST OF ASIA PACIFIC MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 78 REST OF ASIA PACIFIC PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 79 REST OF THE WORLD: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2019-2032 (USD MILLION) TABLE 80 REST OF WORLD: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 81 REST OF WORLD MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 82 REST OF WORLD PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 83 LATIN AMERICA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 84 LATIN AMERICA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 85 LATIN AMERICA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 86 MIDDLE EAST: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 87 MIDDLE EAST MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 88 MIDDLE EAST PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 89 AFRICA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 90 AFRICA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 91 AFRICA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 92 CSL BEHRING: PRODUCTS OFFERED TABLE 93 CSL BEHRING: KEY DEVELOPMENTS TABLE 94 GRIFOLS, S.A: PRODUCTS OFFERED TABLE 95 GRIFOLS: KEY DEVELOPMENTS TABLE 96 BAXTER INTERNATIONAL INC.: PRODUCTS OFFERED TABLE 97 MITSUBISHI TANABE: PRODUCTS OFFERED TABLE 98 TAKEDA PHARMACEUTICAL: PRODUCTS OFFERED TABLE 99 OCTAPHARMA AG.: PRODUCTS OFFERED TABLE 100 HUALAN BIO: PRODUCTS OFFERED TABLE 101 KEDRION SPA: PRODUCTS OFFERED TABLE 102 LFB GROUP.: PRODUCTS OFFERED TABLE 103 BIOTEST AG: PRODUCTS OFFERED
SummaryPlasma Fractionation Market Research Report Forecast to 2030 Table of ContentsTABLE OF CONTENTS1 EXECUTIVE SUMMARY 1.1.1 GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE 1.1.2 GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION 1.1.3 GLOBAL PLASMA FRACTIONATION MARKET, BY END USER 1.1.4 GLOBAL PLASMA FRACTIONATION MARKET, BY REGION 2 MARKET INTRODUCTION 2.1 DEFINITION 2.2 SCOPE OF THE STUDY 2.3 SCOPE OF THE STUDY 2.4 MARKET STRUCTURE 3 RESEARCH METHODOLOGY 3.1 RESEARCH PROCESS 3.2 PRIMARY RESEARCH 3.3 SECONDARY RESEARCH 3.4 MARKET SIZE ESTIMATION 3.5 TOP DOWN & BOTTOM-UP APPROACH 3.6 FORECAST MODEL 3.7 LIST OF ASSUMPTIONS 4 MARKET DYNAMICS 4.1 DRIVERS 4.1.1 GROWING USE OF IMMUNOGLOBULINS FOR VARIOUS THERAPEUTIC AREA 4.1.2 DEMAND FOR PLASMA DERIVED MEDICINAL PRODUCTS DRIVES THE MARKET GROWTH 4.1.3 DRIVER IMPACT ANALYSIS 4.2 RESTRAINTS 4.2.1 EMERGENCE OF RECOMBINANT THERAPIES AS AN ALTERNATIVE TO PLASMA DERIVED MEDICINES RESTRAINTS THE MARKET GROWTH 4.2.2 RESTRAINT IMPACT ANALYSIS 4.3 OPPORTUNITIES 4.3.1 LAUNCH OF NEW TECHNOLOGIES BY KEY PLAYERS TO AUGMENT MARKET GROWTH 5 MARKET FACTOR ANALYSIS 5.1 SUPPLY CHAIN ANALYSIS 5.1.1 RAW APPLICATIONS 5.1.2 MANUFACTURES 5.1.3 DISTRIBUTION 5.1.4 END USER 5.2 PORTER’S FIVE FORCES MODEL 5.2.1 THREAT OF NEW ENTRANTS 5.2.2 BARGAINING POWER OF SUPPLIERS 5.2.3 THREAT OF SUBSTITUTES 5.2.4 BARGAINING POWER OF BUYERS 5.2.5 INTENSITY OF RIVALRY 5.3 MAJOR COLD CHAIN PRODUCTS/DEVICES IN THE PLASMA FRACTIONATION MARKET 5.4 IMPACT OF COVID-19 ON THE GLOBAL PLASMA FRACTIONATION MARKET 5.4.1 IMPACT ON SUPPLY CHAIN 5.4.2 IMPACT ON PRODUCTION 5.4.3 IMPACT ON REGIONS 5.4.4 IMPACT ON DEMAND-SUPPLY GAP ANALYSIS 5.4.5 IMPACT ON PRICING 6 GLOBAL PLASMA FRACTIONATION MARKET, BY PRODUCT TYPE 6.1 OVERVIEW 6.2 IMMUNOGLOBULIN 6.2.1 Intravenous Immunoglobulins 6.2.2 Subcutaneous Immunoglobulins 6.2.3 Others 6.3 COAGULATION FACTOR CONCENTRATES 6.3.1 Factor VIII 6.3.2 Factor IX 6.3.3 Von Willebrand Factor 6.3.4 Prothrombin Complex Concentrate 6.3.5 Fibrinogen Concentrates 6.3.6 Factor XIII 6.4 ALBUMIN 6.5 PROTEASE INHIBITORS 6.6 OTHERS 7 GLOBAL PLASMA FRACTIONATION MARKET, BY APPLICATION 7.1 OVERVIEW 7.2 IMMUNOLOGY 7.3 NEUROLOGY 7.4 HEMATOLOGY 7.5 CRITICAL CARE 7.6 PULMONOLOGY 7.7 RHEUMATOLOGY 7.8 HEMATO-ONCOLOGY 7.9 OTHERS 8 GLOBAL PLASMA FRACTIONATION MARKET, BY END USER 8.1 OVERVIEW 8.2 HOSPITALS & CLINICS 8.3 CLINICAL RESEARCH LABORATORIES 8.4 ACADEMIC INSTITUTES 8.5 OTHERS 9 GLOBAL PLASMA FRACTIONATION, BY REGION 9.1 OVERVIEW 9.2 NORTH AMERICA 9.2.1 US 9.2.2 CANADA 9.3 EUROPE 9.3.1 GERMANY 9.3.2 FRANCE 9.3.3 ITALY 9.3.4 SPAIN 9.3.5 UK 9.3.6 REST OF EUROPE 9.4 ASIA-PACIFIC 9.4.1 CHINA 9.4.2 JAPAN 9.4.3 INDIA 9.4.4 AUSTRALIA 9.4.5 SOUTH KOREA 9.4.6 REST OF ASIA PACIFIC 9.5 REST OF THE WORLD 9.5.1 LATIN AMERICA 9.5.2 MIDDLE EAST 9.5.3 AFRICA 10 COMPETITIVE LANDSCAPE 10.1 COMPETITIVE OVERVIEW 10.2 MAJOR GROWTH STRATEGY IN THE GLOBAL PLASMA FRACTIONATION MARKET 10.3 COMPETITIVE BENCHMARKING 11 COMPANY PROFILES 11.1 CSL BEHRING 11.1.1 COMPANY OVERVIEW 11.1.2 FINANCIAL OVERVIEW 11.1.3 PRODUCTS OFFERED 11.1.4 KEY DEVELOPMENTS 11.1.5 SWOT ANALYSIS 11.1.6 KEY STRATEGIES 11.2 GRIFOLS THERAPEUTICS 11.2.1 COMPANY OVERVIEW 11.2.2 FINANCIAL OVERVIEW 11.2.3 PRODUCTS OFFERED 11.2.4 KEY DEVELOPMENTS 11.2.5 SWOT ANALYSIS 11.2.6 KEY STRATEGIES 11.3 BAXTER INTERNATIONAL INC. 11.3.1 COMPANY OVERVIEW 11.3.2 FINANCIAL OVERVIEW 11.3.3 PRODUCTS OFFERED 11.3.4 KEY DEVELOPMENTS 11.3.5 SWOT ANALYSIS 11.3.6 KEY STRATEGIES 11.4 MITSUBISHI TANABE 11.4.1 COMPANY OVERVIEW 11.4.2 FINANCIAL OVERVIEW 11.4.3 PRODUCTS OFFERED 11.4.4 KEY DEVELOPMENTS 11.4.5 SWOT ANALYSIS 11.4.6 KEY STRATEGIES 11.5 TAKEDA PHARMACEUTICAL 11.5.1 COMPANY OVERVIEW 11.5.2 FINANCIAL OVERVIEW 11.5.3 PRODUCTS OFFERED 11.5.4 KEY DEVELOPMENTS 11.5.5 SWOT ANALYSIS 11.5.6 KEY STRATEGIES 11.6 OCTAPHARMA AG 11.6.1 COMPANY OVERVIEW 11.6.2 FINANCIAL OVERVIEW 11.6.3 PRODUCTS OFFERED 11.6.4 KEY DEVELOPMENTS 11.6.5 SWOT ANALYSIS 11.6.6 KEY STRATEGIES 11.7 HUALAN BIO 11.7.1 COMPANY OVERVIEW 11.7.2 FINANCIAL OVERVIEW 11.7.3 PRODUCTS OFFERED 11.7.4 KEY DEVELOPMENTS 11.8 KEDRION S.P.A 11.8.1 COMPANY OVERVIEW 11.8.2 FINANCIAL OVERVIEW 11.8.3 PRODUCTS OFFERED 11.8.4 KEY DEVELOPMENTS 11.9 LFB GROUP 11.9.1 COMPANY OVERVIEW 11.9.2 FINANCIAL OVERVIEW 11.9.3 PRODUCTS OFFERED 11.9.4 KEY DEVELOPMENTS 11.10 BIOTEST AG 11.10.1 COMPANY OVERVIEW 11.10.2 FINANCIAL OVERVIEW 11.10.3 PRODUCTS OFFERED 11.10.4 KEY DEVELOPMENTS 11.10.5 SWOT ANALYSIS 11.10.6 KEY STRATEGIES List of Tables/GraphsLIST OF TABLESTABLE 1 LIST OF ASSUMPTIONS TABLE 2 GLOBAL PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 3 IMMUNOGLOBULIN: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 4 IMMUNOGLOBULIN: MARKET ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD MILLION) TABLE 5 COAGULATION FACTOR CONCENTRATES: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 6 COAGULATION FACTOR CONCENTRATES: MARKET ESTIMATES & FORECAST, BY TYPE, 2019-2032 (USD MILLION) TABLE 7 ALBUMIN: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 8 PROTEASE INHIBITORS: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 9 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 10 GLOBAL PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 11 IMMUNOLOGY: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 12 NEUROLOGY: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 13 HEMATOLOGY: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 14 CRITICAL CARE: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 15 PULMONOLOGY: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 16 RHEUMATOLOGY: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 17 HEMATO-ONCOLOGY: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 18 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 19 GLOBAL PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 20 HOSPITALS & CLINICS: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 21 CLINICAL RESEARCH LABORATORIES: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 22 ACADEMIC INSTITUTES: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 23 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 24 GLOBAL PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY REGION, 2019-2032 (USD MILLION) TABLE 25 NORTH AMERICA: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2019-2032 (USD MILLION) TABLE 26 NORTH AMERICA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 27 NORTH AMERICA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 28 NORTH AMERICA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 29 US: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 30 US MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 31 US PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 32 CANADA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 33 CANADA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 34 CANADA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 35 EUROPE: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2019-2032 (USD MILLION) TABLE 36 EUROPE: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 37 EUROPE MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 38 EUROPE PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 39 GERMANY: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 40 GERMANY MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 41 GERMANY PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 42 FRANCE: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 43 FRANCE MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 44 FRANCE PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 45 ITALY: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 46 ITALY MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 47 ITALY PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 48 SPAIN: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 49 SPAIN MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 50 SPAIN PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 51 UK: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 52 UK MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 53 UK PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 54 REST OF EUROPE: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 55 REST OF EUROPE MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 56 REST OF EUROPE PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 57 ASIA-PACIFIC: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2019-2032 (USD MILLION) TABLE 58 ASIA PACIFIC: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 59 ASIA PACIFIC MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 60 ASIA PACIFIC PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 61 CHINA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 62 CHINA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 63 CHINA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 64 JAPAN: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 65 JAPAN MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 66 JAPAN PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 67 INDIA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 68 INDIA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 69 INDIA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 70 AUSTRALIA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 71 AUSTRALIA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 72 AUSTRALIA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 73 SOUTH KOREA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 74 SOUTH KOREA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 75 SOUTH KOREA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 76 REST OF ASIA PACIFIC: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 77 REST OF ASIA PACIFIC MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 78 REST OF ASIA PACIFIC PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 79 REST OF THE WORLD: MARKET ESTIMATES & FORECAST, BY COUNTRY, 2019-2032 (USD MILLION) TABLE 80 REST OF WORLD: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 81 REST OF WORLD MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 82 REST OF WORLD PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 83 LATIN AMERICA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 84 LATIN AMERICA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 85 LATIN AMERICA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 86 MIDDLE EAST: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 87 MIDDLE EAST MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 88 MIDDLE EAST PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 89 AFRICA: MARKET ESTIMATES, BY PRODUCT TYPE, 2019-2032 (USD MILLION) TABLE 90 AFRICA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2019-2032 (USD MILLION) TABLE 91 AFRICA PLASMA FRACTIONATION MARKET ESTIMATES & FORECAST, BY END USER, 2019-2032 (USD MILLION) TABLE 92 CSL BEHRING: PRODUCTS OFFERED TABLE 93 CSL BEHRING: KEY DEVELOPMENTS TABLE 94 GRIFOLS, S.A: PRODUCTS OFFERED TABLE 95 GRIFOLS: KEY DEVELOPMENTS TABLE 96 BAXTER INTERNATIONAL INC.: PRODUCTS OFFERED TABLE 97 MITSUBISHI TANABE: PRODUCTS OFFERED TABLE 98 TAKEDA PHARMACEUTICAL: PRODUCTS OFFERED TABLE 99 OCTAPHARMA AG.: PRODUCTS OFFERED TABLE 100 HUALAN BIO: PRODUCTS OFFERED TABLE 101 KEDRION SPA: PRODUCTS OFFERED TABLE 102 LFB GROUP.: PRODUCTS OFFERED TABLE 103 BIOTEST AG: PRODUCTS OFFERED
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
Market Research Future社の医療分野での最新刊レポート
本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問Market Research Future社はどのような調査会社ですか?マーケットリサーチフューチャー(Market Research Future)は世界市場を幅広く調査し、主要分野、地域、国レベルの調査レポートを出版しています。 下記分野については、分野毎に専... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|